These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 5803940)
1. [Norgestrel and ethinyl estradiol. New oral agent of controlled dosage for regulating fertility]. Rice-Wray E; Avila C; Gutiérrez J Rev Colomb Obstet Ginecol; 1969; 20(2):61-8. PubMed ID: 5803940 [No Abstract] [Full Text] [Related]
2. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg. Christie T J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701 [No Abstract] [Full Text] [Related]
3. Prescribing an oral contraceptive for the individual woman. Chick P Aust Fam Physician; 1980 Feb; Suppl():8-12. PubMed ID: 6444808 [TBL] [Abstract][Full Text] [Related]
7. [Experimental use of the new generation of Tri-Step contraceptive agents in 20 treated cases]. Spasojević M Med Arh; 1984; 38(2):83-4. PubMed ID: 6444082 [No Abstract] [Full Text] [Related]
8. [Clinical study of low-dose oral contraceptives (with low-doses of ethinyl estradiol), widely used in practice]. Nalbanski B; Tsekova K; Ivanov S Akush Ginekol (Sofiia); 2001; 41 Suppl 4():20-3. PubMed ID: 11519317 [No Abstract] [Full Text] [Related]
9. Clinical experience with a low-dose contraceptive agent. European studies. Haspels AA J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703 [TBL] [Abstract][Full Text] [Related]
10. Fertility control with Ovral. A clinical review. Laurie RE; Lewis ET J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:95-107. PubMed ID: 4256548 [No Abstract] [Full Text] [Related]
11. [Restovar, a new combined oral contraceptive with a low estrogen content]. Fondu F; Lowijck J Brux Med; 1974 Aug; 54(8):453-8. PubMed ID: 4425958 [No Abstract] [Full Text] [Related]
12. [Our experiences with the long-term use of the oral low-dosage contraceptive Bisecurin]. Marjanović M; Berić BM Med Pregl; 1975; 28(9-10):425-7. PubMed ID: 1186615 [No Abstract] [Full Text] [Related]
13. [Sequential therapy in menstruation disorders]. Gaudefroy M; Lefebvre F J Sci Med Lille; 1968 Oct; 86(10):581-606. PubMed ID: 4097276 [No Abstract] [Full Text] [Related]
14. Further investigations concerning bisecurin, a peroral contraceptive of low hormonal contents. Bencsik A Ther Hung; 1973; 21(2):79-81. PubMed ID: 4792882 [No Abstract] [Full Text] [Related]
15. [Ovulation inhibition with low dosage gestagen components. Results of international clinical trial of Orlest]. Figoureux J; Onghena G; Schlikker E; Wattiez M; Schlösser W; Vercautere E; William P Munch Med Wochenschr; 1967 Dec; 109(48):2555-8. PubMed ID: 5631905 [No Abstract] [Full Text] [Related]
16. The antiovulatory effect of ethinyl oestradiol in sequential therapy. Buus JG; Bang HO; Berthelsen HG Dan Med Bull; 1967 Jun; 14(7):161-4. PubMed ID: 6047306 [No Abstract] [Full Text] [Related]
17. [Ovostat 22, a new oral contraceptive]. Himmelsbach H Med Welt; 1974 Jan; 25(3):106-8. PubMed ID: 4840796 [No Abstract] [Full Text] [Related]